Jian Ye

Showing 1-7 of 7 articles

Interventions for valvular disease

Reference dimensions to determine valve size of stented surgical aortic bioprostheses by computed tomography

Anastasius M, Godoy M, Weir-McCall JR, Bapat V, Sathananthan J, Hensey M, Sellers S, Cheung A, Ye J, Wood D, Leipsic J, Webb J, Blanke P

February 4, 2020 | 10.4244/EIJ-D-19-00921

Interventions for valvular disease

First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system

Hensey M, Murdoch D, Sathananthan J, Alenezi A, Sathananthan G, Moss R, Blanke P, Leipsic J, Wood D, Cheung A, Ye J, Webb J

February 7, 2019 | 10.4244/EIJ-D-18-00935

Interventions for valvular disease

Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experience

Perlman G, Cheung A, Dumont E, Stub D, Dvir D, Del Trigo M, Pelletier M, Alnasser S, Ye J, Wood D, Thompson C, Blanke P, Leipsic J, Seidman M, LeBlanc H, Buller C, Rodés-Cabau J, Webb J

January 20, 2017 | 10.4244/EIJ-D-16-00299

Interventions for valvular disease

In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves

Simonato M, Azadani A, Webb J, Leipsic J, Kornowski R, Vahanian A, Wood D, Piazza N, Kodali S, Ye J, Whisenant B, Gaia D, Aziz M, Pasala T, Mehilli J, Wijeysundera H, Tchétché D, Moat N, Teles R, Petronio A, Hildick-Smith D, Landes U, Windecker S, Arbel Y, Mendiz O, Makkar R, Tseng E, Dvir D

September 18, 2016 | 10.4244/EIJV12I7A149

Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement

Barbanti M, Binder R, Freeman M, Wood D, Leipsic J, Cheung A, Ye J, Tan J, Toggweiler S, Yang T-H, Dvir D, Maryniak K, Lauck S, Webb J

December 27, 2013 | 10.4244/EIJV9I8A156

The Helio transcatheter aortic dock for patients with aortic regurgitation

Barbanti M, Ye J, Pasupati S, El-Gamel A, Webb J

September 15, 2013 | 10.4244/EIJV9SSA17

Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines

Gurvitch R, Toggweiler S, Willson A, Wijesinghe N, Cheung A, Wood D, Ye J, Webb J

May 17, 2011 | 10.4244/EIJV7I1A10

1

Latest news

"Shocktopics” with intravascular lithotripsy, bioprosthetic valve fracture, myocardial fibrosis in TAVI...

Reimaged models and angiograms showing CO March 17, 2020

New ahead of print: Infolding of self expanding valve during transcatheter aortic valve implantation

Nandhakumar Vasu et al

Bioresorbable scaffolds and STEMI: an ideal setting, but still vacant

Christian Spaulding

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

Defining procedural MI - does it matter (spoiler alert - it does!)

This week’s JAA’s: QFR in severe AS & Infection control for TAVI

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke